Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Cadila Healthcare submits press release

24 Jul 2019

Cadila Healthcare has informed about submission of a copy of press release dated July 24, 2019 titled ‘Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Related Cadila Healthcare Ltd. Links:

Cadila Healthcare Share Price

544.60 -1.75 (-0.32%) Sep 21, 09:53
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 758.45
Cipla 945.00
Dr. Reddy's Lab 4798.40
Aurobindo Pharma 719.70
Lupin 934.20
View more..
Sensex vs Cadila Healthcare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback